A phase II trial of CI-921 in advanced malignancies.
Sklarin NT, Wiernik PH, Grove WR, Benson L, Mittelman A, Maroun JA, Stewart JA, Robert F, Doroshow JH, Rosen PJ, et al.
Sklarin NT, et al. Among authors: wiernik ph.
Invest New Drugs. 1992 Nov;10(4):309-12. doi: 10.1007/BF00944186.
Invest New Drugs. 1992.
PMID: 1487405
Clinical Trial.